These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Regulation of multiple angiogenic pathways by Dll4 and Notch in human umbilical vein endothelial cells. Harrington LS; Sainson RC; Williams CK; Taylor JM; Shi W; Li JL; Harris AL Microvasc Res; 2008 Mar; 75(2):144-54. PubMed ID: 17692341 [TBL] [Abstract][Full Text] [Related]
25. Up-regulation of the Notch ligand Delta-like 4 inhibits VEGF-induced endothelial cell function. Williams CK; Li JL; Murga M; Harris AL; Tosato G Blood; 2006 Feb; 107(3):931-9. PubMed ID: 16219802 [TBL] [Abstract][Full Text] [Related]
26. GIT1 regulates angiogenic factor secretion in bone marrow mesenchymal stem cells via NF-κB/Notch signalling to promote angiogenesis. Li L; Tang P; Zhou Z; Wang Q; Xu T; Zhao S; Huang Y; Kong F; Liu W; Cheng L; Zhou Z; Zhao X; Gu C; Luo Y; Tao G; Qian D; Chen J; Fan J; Yin G Cell Prolif; 2019 Nov; 52(6):e12689. PubMed ID: 31502302 [TBL] [Abstract][Full Text] [Related]
27. Substrate stiffness modulates endothelial cell function via the YAP-Dll4-Notch1 pathway. Matsuo E; Okamoto T; Ito A; Kawamoto E; Asanuma K; Wada K; Shimaoka M; Takao M; Shimamoto A Exp Cell Res; 2021 Nov; 408(1):112835. PubMed ID: 34543658 [TBL] [Abstract][Full Text] [Related]
28. Angiopoietin-1/Tie2 signal augments basal Notch signal controlling vascular quiescence by inducing delta-like 4 expression through AKT-mediated activation of beta-catenin. Zhang J; Fukuhara S; Sako K; Takenouchi T; Kitani H; Kume T; Koh GY; Mochizuki N J Biol Chem; 2011 Mar; 286(10):8055-8066. PubMed ID: 21212269 [TBL] [Abstract][Full Text] [Related]
29. Specific NOTCH1 antibody targets DLL4-induced proliferation, migration, and angiogenesis in NOTCH1-mutated CLL cells. López-Guerra M; Xargay-Torrent S; Fuentes P; Roldán J; González-Farré B; Rosich L; Silkenstedt E; García-León MJ; Lee-Vergés E; Giménez N; Giró A; Aymerich M; Villamor N; Delgado J; López-Guillermo A; Puente XS; Campo E; Toribio ML; Colomer D Oncogene; 2020 Feb; 39(6):1185-1197. PubMed ID: 31616059 [TBL] [Abstract][Full Text] [Related]
30. Spatial patterning of the Notch ligand Dll4 controls endothelial sprouting in vitro. Tiemeijer LA; Frimat JP; Stassen OMJA; Bouten CVC; Sahlgren CM Sci Rep; 2018 Apr; 8(1):6392. PubMed ID: 29686270 [TBL] [Abstract][Full Text] [Related]
31. TRIM28 regulates sprouting angiogenesis through VEGFR-DLL4-Notch signaling circuit. Wang Y; Singh AR; Zhao Y; Du T; Huang Y; Wan X; Mukhopadhyay D; Wang Y; Wang N; Zhang P FASEB J; 2020 Nov; 34(11):14710-14724. PubMed ID: 32918765 [TBL] [Abstract][Full Text] [Related]
32. Synchronization of endothelial Dll4-Notch dynamics switch blood vessels from branching to expansion. Ubezio B; Blanco RA; Geudens I; Stanchi F; Mathivet T; Jones ML; Ragab A; Bentley K; Gerhardt H Elife; 2016 Apr; 5():. PubMed ID: 27074663 [TBL] [Abstract][Full Text] [Related]
33. Cross-talk between leukemic and endothelial cells promotes angiogenesis by VEGF activation of the Notch/Dll4 pathway. Zhang J; Ye J; Ma D; Liu N; Wu H; Yu S; Sun X; Tse W; Ji C Carcinogenesis; 2013 Mar; 34(3):667-77. PubMed ID: 23239744 [TBL] [Abstract][Full Text] [Related]
34. MicroRNA-384-5p Promotes Endothelial Progenitor Cell Proliferation and Angiogenesis in Cerebral Ischemic Stroke through the Delta-Likeligand 4-Mediated Notch Signaling Pathway. Fan J; Xu W; Nan S; Chang M; Zhang Y Cerebrovasc Dis; 2020; 49(1):39-54. PubMed ID: 31927543 [TBL] [Abstract][Full Text] [Related]
35. Implications of Dll4-Notch signaling activation in primary glioblastoma multiforme. El Hindy N; Keyvani K; Pagenstecher A; Dammann P; Sandalcioglu IE; Sure U; Zhu Y Neuro Oncol; 2013 Oct; 15(10):1366-78. PubMed ID: 23787764 [TBL] [Abstract][Full Text] [Related]
36. Arsenic Trioxide Suppresses Tumor Growth through Antiangiogenesis via Notch Signaling Blockade in Small-Cell Lung Cancer. Yang MH; Chang KJ; Li B; Chen WS Biomed Res Int; 2019; 2019():4647252. PubMed ID: 31093499 [TBL] [Abstract][Full Text] [Related]
37. MEDI0639: a novel therapeutic antibody targeting Dll4 modulates endothelial cell function and angiogenesis in vivo. Jenkins DW; Ross S; Veldman-Jones M; Foltz IN; Clavette BC; Manchulenko K; Eberlein C; Kendrew J; Petteruti P; Cho S; Damschroder M; Peng L; Baker D; Smith NR; Weir HM; Blakey DC; Bedian V; Barry ST Mol Cancer Ther; 2012 Aug; 11(8):1650-60. PubMed ID: 22679110 [TBL] [Abstract][Full Text] [Related]
38. Notch1 signaling in NOTCH1-mutated mantle cell lymphoma depends on Delta-Like ligand 4 and is a potential target for specific antibody therapy. Silkenstedt E; Arenas F; Colom-Sanmartí B; Xargay-Torrent S; Higashi M; Giró A; Rodriguez V; Fuentes P; Aulitzky WE; van der Kuip H; Beà S; Toribio ML; Campo E; López-Guerra M; Colomer D J Exp Clin Cancer Res; 2019 Nov; 38(1):446. PubMed ID: 31676012 [TBL] [Abstract][Full Text] [Related]
39. Extracellular vesicle-carried Jagged-1 inhibits HUVEC sprouting in a 3D microenvironment. Tan E; Asada HH; Ge R Angiogenesis; 2018 Aug; 21(3):571-580. PubMed ID: 29541959 [TBL] [Abstract][Full Text] [Related]
40. Inhibition of delta-like-4-mediated signaling impairs reparative angiogenesis after ischemia. Al Haj Zen A; Oikawa A; Bazan-Peregrino M; Meloni M; Emanueli C; Madeddu P Circ Res; 2010 Jul; 107(2):283-93. PubMed ID: 20508179 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]